BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, Oh EJ. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP. World J Gastroenterol 2013; 19(3): 339-346 [PMID: 23372355 DOI: 10.3748/wjg.v19.i3.339]
URL: https://www.wjgnet.com/1007-9327/full/v19/i3/339.htm
Number Citing Articles
1
Masataka Maruno, Katsunori Imai, Yosuke Nakao, Yuki Kitano, Takayoshi Kaida, Kosuke Mima, Hiromitsu Hayashi, Yo-Ichi Yamashita, Yoshiki Mikami, Hideo Baba. Multiple hepatic inflammatory pseudotumors with elevated alpha-fetoprotein and alpha-fetoprotein lectin 3 fraction with various PET accumulations: a case reportSurgical Case Reports 2021; 7(1) doi: 10.1186/s40792-021-01188-6
2
Siyuan Chen, Junhong Li, Xiaodan Tan, Qi Xu, Yuncong Mo, Hongyan Qin, Lili Zhou, Lingxiu Ma, Zhixiao Wei. Clinical role of combining alpha‐fetoprotein and lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein for hepatocellular carcinoma: Evidence from literature and an original studyJournal of Clinical Laboratory Analysis 2020; 34(7) doi: 10.1002/jcla.23262
3
Huaping Chen, Siyuan Chen, Shan Li, Zhijian Chen, Xuan Zhu, Meiyu Dai, Lingxi Kong, Xiaodan Lv, Zhili Huang, Xue Qin. Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation studyOncotarget 2017; 8(52): 90390 doi: 10.18632/oncotarget.20153
4
Valentina Peta, Jianhui Zhu, David M. Lubman, Samuel Huguet, Francoise Imbert-Bismutd, Gérard Bolbach, Gilles Clodic, Lucrèce Matheron, Yen Ngo, Pais Raluca, Chantal Housset, Keyvan Rezai, Thierry Poynard. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver diseaseClinics and Research in Hepatology and Gastroenterology 2020; 44(5): 681 doi: 10.1016/j.clinre.2019.12.010
5
Jiaxin Zhang, Guang Chen, Peng Zhang, Jiaying Zhang, Xiaoke Li, Da’nan Gan, Xu Cao, Mei Han, Hongbo Du, Yong’an Ye, Gianfranco D. Alpini. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysisPLOS ONE 2020; 15(2): e0228857 doi: 10.1371/journal.pone.0228857
6
Hao-Guang Wan, Hao Xu, Yu-Ming Gu, Hui Wang, Wei Xu, Mao-Heng Zu. Comparison osteopontin vs AFP for the diagnosis of HCC: A meta-analysisClinics and Research in Hepatology and Gastroenterology 2014; 38(6): 706 doi: 10.1016/j.clinre.2014.06.008
7
Hao Xing, Yi-Jie Zheng, Jun Han, Han Zhang, Zhen-Li Li, Wan-Yee Lau, Feng Shen, Tian Yang. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysisHepatobiliary & Pancreatic Diseases International 2018; 17(6): 487 doi: 10.1016/j.hbpd.2018.09.009
8
Elisabetta Degasperi, Riccardo Perbellini, Roberta D’Ambrosio, Sara Colonia Uceda Renteria, Ferruccio Ceriotti, Alberto Perego, Corinna Orsini, Marta Borghi, Massimo Iavarone, Mariangela Bruccoleri, Alessandro Rimondi, Annalisa De Silvestri, Angelo Sangiovanni, Pietro Lampertico. Prothrombin induced by vitamin K absence or antagonist‐II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C‐related cirrhosis treated with direct‐acting antiviral agentsAlimentary Pharmacology & Therapeutics 2022; 55(3): 350 doi: 10.1111/apt.16685
9
Clemens Schotten, Bastian Ostertag, Jan-Peter Sowa, Paul Manka, Lars P. Bechmann, Gudrun Hilgard, Claudio Marquardt, Marc Wichert, Hidenori Toyoda, Christian M. Lange, Ali Canbay, Philip Johnson, Heiner Wedemeyer, Jan Best. GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C PatientsPharmaceuticals 2021; 14(8): 735 doi: 10.3390/ph14080735
10
Tetsuhiro Chiba, Eiichiro Suzuki, Tomoko Saito, Sadahisa Ogasawara, Yoshihiko Ooka, Akinobu Tawada, Atsushi Iwama, Osamu Yokosuka. Biological features and biomarkers in hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(16): 2020-2028 doi: 10.4254/wjh.v7.i16.2020
11
Jia Fan, Yu Chen, Dan Zhang, Juan Yao, Zijun Zhao, Yao Jiang, Yiqin Li, Yongcan Guo. Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysisSurgical Oncology 2020; 34: 245 doi: 10.1016/j.suronc.2020.05.002
12
Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Ying He, Magdalena Swiatek‐de Lange, David Morgenstern, Henry Lik‐Yuen Chan. Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control StudyHepatology Communications 2021;  doi: 10.1002/hep4.1847
13
Sang Joon Park, Jae Young Jang, Soung Won Jeong, Young Kyu Cho, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Hae In Bang. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinomaMedicine 2017; 96(11): e5811 doi: 10.1097/MD.0000000000005811
14
Stijn Van Hees, Peter Michielsen, Thomas Vanwolleghem. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(37): 8271-8282 doi: 10.3748/wjg.v22.i37.8271
15
Tung-Hung Su, Cheng-Yuan Peng, Shan-Han Chang, Tai-Chung Tseng, Chun-Jen Liu, Chi-Ling Chen, Chen-Hua Liu, Hung-Chih Yang, Pei-Jer Chen, Jia-Horng Kao. Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosisJournal of the Formosan Medical Association 2021;  doi: 10.1016/j.jfma.2021.08.003
16
Iman A. Abd El Gawad, Ghada I. Mossallam, Noha H. Radwan, Heba M. Elzawahry, Niveen M. Elhifnawy. Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patientsJournal of the Egyptian National Cancer Institute 2014; 26(2): 79 doi: 10.1016/j.jnci.2014.01.001
17
Suresh K. Kailasa, Vaibhavkumar N. Mehta, Jigneshkumar V. Rohit. Miniaturized Analytical Devices2022; : 1 doi: 10.1002/9783527827213.ch1
18
Han Ah Lee, Yoo Ra Lee, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Kwan Soo Byun, Yeon Seok Seo. <i>Lens culinaris</i> agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinomaWorld Journal of Gastroenterology 2021; 27(28): 4687-4696 doi: 10.3748/wjg.v27.i28.4687
19
Ting Wang, Kun-He Zhang. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular CarcinomaFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01316
20
Eric Waidely, Abdul-Rahman Obaid Al-Yuobi, A. S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Serum protein biomarkers relevant to hepatocellular carcinoma and their detectionThe Analyst 2016; 141(1): 36 doi: 10.1039/C5AN01884F
21
Minghui Wang, Zhijun Zhang, Deng Pan, Zhigang Xin, Fan Bu, Yue Zhang, Qingwu Tian, Xiaodong Feng. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancerBioscience Reports 2021; 41(7) doi: 10.1042/BSR20211115
22
Wan-Ju Xu, Bao-Li Guo, Yu-Gang Han, Lei Shi, Wan-Shan Ma. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levelsTumor Biology 2014; 35(12): 12069 doi: 10.1007/s13277-014-2506-8
23
Neeral L. Shah, Nicolas M. Intagliata, Patrick G. Northup, Curtis K. Argo, Stephen H. Caldwell. Procoagulant therapeutics in liver disease: a critique and clinical rationaleNature Reviews Gastroenterology & Hepatology 2014; 11(11): 675 doi: 10.1038/nrgastro.2014.121
24
Fei Xu, Lulu Zhang, Wenting He, Di Song, Xiaomeng Ji, Jianyong Shao, Jie Mei. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma PatientsDisease Markers 2021; 2021: 1 doi: 10.1155/2021/8868370
25
J.F. Schlaak. Labordiagnostik bei primärem LeberzellkarzinomDer Gastroenterologe 2014; 9(2): 138 doi: 10.1007/s11377-013-0839-2
26
Xiao-Qiong Tang, Hong Li, Li-Bo Yan, Ling-Yun Zhou, En-Qiang Chen, Miao Liu, Dong-Mei Zhang, Hong Tang. Diagnostic value of PIVKA-II in detecting hepatocellular carcinomaFuture Virology 2017; 12(5): 259 doi: 10.2217/fvl-2017-0017
27
Shujing Huang, Feifei Jiang, Ying Wang, Yanhua Yu, Siqian Ren, Xiaowei Wang, Peng Yin, Jinli Lou. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patientsTumor Biology 2017; 39(6): 101042831770576 doi: 10.1177/1010428317705763
28
Jiang-feng Xu, Xi-yu Liu. PIVKA-II is an independent prognostic factor for overall survival of HCC patients and maybe associated with epithelial-mesenchymal transitionJournal of Hepatology 2015; 63(4): 1040 doi: 10.1016/j.jhep.2015.04.031
29
Shilu Mathew, Ashraf Ali, Hany Abdel-Hafiz, Kaneez Fatima, Mohd Suhail, Govindaraju Archunan, Nargis Begum, Syed Jahangir, Muhammad Ilyas, Adeel G.A. Chaudhary, Mohammad Al Qahtani, Salem Mohamad Bazarah, Ishtiaq Qadri. Biomarkers for virus-induced hepatocellular carcinoma (HCC)Infection, Genetics and Evolution 2014; 26: 327 doi: 10.1016/j.meegid.2014.06.014
30
See-Lok Ho, Di Xu, Man Shing Wong, Hung-Wing Li. Direct and multiplex quantification of protein biomarkers in serum samples using an immuno-magnetic platformChemical Science 2016; 7(4): 2695 doi: 10.1039/C5SC04115E
31
Kazuo Tarao, Akito Nozaki, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka, Makoto Chuma, Kazushi Numata, Shin Maeda. Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of casesWorld Journal of Hepatology 2020; 12(11): 1046-1054 doi: 10.4254/wjh.v12.i11.1046
32
Jinhui Zhu, Kai Yu, Ramon Andrade de Mello. International Manual of Oncology Practice2015; : 327 doi: 10.1007/978-3-319-21683-6_16
33
Fayza A. Rahamtalla, Mohammed S. M. Abdalla, Salma B. M. Mudawi, Mohammed A. H. Kheir Elsid, Iman M. Shammat. Estimation of telomerase, AFP, and AFP-L3 levels in Sudanese patients with hepatocellular carcinoma and chronic liver diseasesComparative Clinical Pathology 2018; 27(5): 1133 doi: 10.1007/s00580-018-2709-2
34
Hao Ma, Xiaoying Sun, Lei Chen, Weina Cheng, Xiao Xia Han, Bing Zhao, Chengyan He. Multiplex Immunochips for High-Accuracy Detection of AFP-L3% Based on Surface-Enhanced Raman Scattering: Implications for Early Liver Cancer DiagnosisAnalytical Chemistry 2017; 89(17): 8877 doi: 10.1021/acs.analchem.7b01349
35
Chenjun Huang, Meng Fang, Xiao Xiao, Hong Wang, Zhiyuan Gao, Jun Ji, Lijuan Liu, Erli Gu, Ya Li, Mengmeng Wang, Chunfang Gao. Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter studyLiver International 2022; 42(1): 210 doi: 10.1111/liv.15082
36
Makoto Meguro, Toru Mizuguchi, Toshihiko Nishidate, Kenji Okita, Masayuki Ishii, Shigenori Ota, Tomomi Ueki, Emi Akizuki, Koichi Hirata. Prognostic roles of preoperative &alpha;-fetoprotein and des-&gamma;-carboxy prothrombin in hepatocellular carcinoma patientsWorld Journal of Gastroenterology 2015; 21(16): 4933-4945 doi: 10.3748/wjg.v21.i16.4933
37
Ghassan K. Abou-Alfa, Lin Wu, Augusto Villanueva. Novel Non-Protein Biomarkers for Early Detection of Hepatocellular CarcinomaEngineering 2021; 7(10): 1369 doi: 10.1016/j.eng.2021.02.020
38
Ji De, Yi Shen, Jinyu Qin, Li Feng, Yiping Wang, Li Yang. A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular CarcinomaMedicine 2016; 95(17): e3448 doi: 10.1097/MD.0000000000003448
39
ImanM.S El-Bagory, AmalA El-Aleem, NessrenM.B El-Deen Mohamed, SalwaA El-Latif Shendy. Serum level of cluster of differentiation 166 as novel biomarker in hepatocellular carcinomaThe Scientific Journal of Al-Azhar Medical Faculty, Girls 2019; 3(3): 573 doi: 10.4103/sjamf.sjamf_30_19
40
Wenling Zhang, Yumei Huang, Jian Xu. Clinical Molecular Diagnostics2021; : 261 doi: 10.1007/978-981-16-1037-0_21
41
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver diseaseCochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013346.pub2
42
Hongyu Liu, Baoguo Li. The functional role of exosome in hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology 2018; 144(11): 2085 doi: 10.1007/s00432-018-2712-7
43
Xiaoyan Yi, Shuang Yu, Yixi Bao. Alpha-fetoprotein-L3 in hepatocellular carcinoma: A meta-analysisClinica Chimica Acta 2013; 425: 212 doi: 10.1016/j.cca.2013.08.005
44
Alain Wuethrich, Joselito P. Quirino. A decade of microchip electrophoresis for clinical diagnostics – A review of 2008–2017Analytica Chimica Acta 2019; 1045: 42 doi: 10.1016/j.aca.2018.08.009
45
Ji Won Han, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Tatsuo Kanda. Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinomaPLOS ONE 2021; 16(12): e0260311 doi: 10.1371/journal.pone.0260311
46
Aiying Zhang, Sven Skog, Shengqi Wang, Yang Ke, Yonghong Zhang, Kang Li, Ellen He, Ning Li. A Chemiluminescent Protein Microarray Method for Determining the Seroglycoid Fucosylation IndexScientific Reports 2016; 6(1) doi: 10.1038/srep31132
47
Jan Best, Lars P. Bechmann, Jan-Peter Sowa, Svenja Sydor, Alexander Dechêne, Kristina Pflanz, Sotiria Bedreli, Clemens Schotten, Andreas Geier, Thomas Berg, Janett Fischer, Arndt Vogel, Heike Bantel, Arndt Weinmann, Jörn M. Schattenberg, Yvonne Huber, Henning Wege, Johann von Felden, Kornelius Schulze, Dominik Bettinger, Robert Thimme, Friedrich Sinner, Kerstin Schütte, Karl Heinz Weiss, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Sarah Berhane, Marc Wichert, Dominik Heider, Guido Gerken, Philip Johnson, Ali Canbay. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology 2020; 18(3): 728 doi: 10.1016/j.cgh.2019.11.012
48
Vincent L. Chen, Pratima Sharma. Role of Biomarkers and Biopsy in Hepatocellular CarcinomaClinics in Liver Disease 2020; 24(4): 577 doi: 10.1016/j.cld.2020.07.001
49
Alessandro Loglio, Massimo Iavarone, Floriana Facchetti, Dhanai Di Paolo, Riccardo Perbellini, Giovanna Lunghi, Ferruccio Ceriotti, Claudio Galli, Maria T. Sandri, Mauro Viganò, Angelo Sangiovanni, Massimo Colombo, Pietro Lampertico. The combination of PIVKA‐II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long‐term oral therapyLiver International 2020; 40(8): 1987 doi: 10.1111/liv.14475
50
Honglei Feng, Bole Li, Ze Li, Qian Wei, Li Ren. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinomaBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08138-3
51
Manar M. Ismail, Heba K. Morsi, Nahla A. B. Abdulateef, Maissa K. Noaman, Ghada A. Abou El-Ella. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillanceScandinavian Journal of Clinical and Laboratory Investigation 2017; 77(3): 175 doi: 10.1080/00365513.2017.1286684
52
JIAN ZHANG, CHUXIAO SHAO, QINGYUN ZHOU, YIMIN ZHU, JINDE ZHU, CHAOYONG TU. Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysisMolecular and Clinical Oncology 2015; 3(5): 1165 doi: 10.3892/mco.2015.600
53
Famei Qi, Aihua Zhou, Li Yan, Xiumei Yuan, Danni Wang, Ruoyun Chang, Yujun Zhang, Funa Shi, Xiaomei Han, Jinxia Hou, Lianhua Wei, Xu Zhang. The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinomaJournal of Clinical Laboratory Analysis 2020; 34(5) doi: 10.1002/jcla.23158
54
Mahmoud M. Kamel, Mohamed F. Saad, Amal A. Mahmoud, Awatief A. Edries, Ahmed S. Abdel-Moneim. Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinomaMicrobial Pathogenesis 2014; 77: 31 doi: 10.1016/j.micpath.2014.10.009
55
E-Na Qian, Shuang-Yin Han, Song-Ze Ding, Xun Lv. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinomaCancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0332-3
56
Yu‑Xue Gao, Tong‑Wang Yang, Ji‑Ming Yin, Peng‑Xiang Yang, Bu‑Xin Kou, Meng‑Yin Chai, Xiao‑Ni Liu, De‑Xi Chen. Progress and prospects of biomarkers in�primary liver cancer (Review)International Journal of Oncology 2020;  doi: 10.3892/ijo.2020.5035